Boehringer Ingelheim · 2 days ago
Principal Scientist, Innovation Management, Fremont CA
Boehringer Ingelheim is a global leader in biopharmaceuticals, and they are seeking a Principal Scientist in Innovation Management. This role involves leading upstream drug substance development and manufacturing, implementing digital tools and data analytics, and scouting emerging technologies to enhance biopharmaceutical manufacturing.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Ensures direct report (intern & co-ops) safety, training, and supervision
Responsible for effective management of a team of technical experts. This is an individual contributor Role
Leads the development and optimization of upstream processes for biopharmaceutical production
Oversees cell culture operations, including media development, bioreactor design, and scale-up processes
Ensures compliance with regulatory standards and quality control measures
Collaborates with cross-functional teams to integrate upstream processes with downstream and analytical development
Implements digital tools and data analytics to enhance process understanding and control
Develops and applies predictive models for process optimization and troubleshooting
Utilizes machine learning and AI to drive continuous improvement in manufacturing processes
Manages data integrity and ensures robust data management practices
Identifies and evaluates emerging technologies and companies that can enhance biopharmaceutical manufacturing
Conducts due diligence and feasibility assessments for potential technology acquisitions or partnerships
Collaborates with global teams to integrate new technologies into existing processes
Stays abreast of industry trends and advancements to maintain a competitive edge
Provides scientific and technical leadership to the upstream development team
Mentors and develops team members, fostering a collaborative and high-performance culture
Manages project timelines, budgets, and resources effectively
Represents the company at industry conferences and scientific meetings
Qualification
Required
BS with ten-plus (10+) years' experience in Chemical/Biochemical Engineering, Bioengineering, Biochemistry, Biology, or related scientific field
OR
MS with six-plus (6+) years' experience in Chemical/Biochemical Engineering, Bioengineering, Biochemistry, Biology, or related scientific field
OR
PhD with three-plus (3+) years' experience in Chemical/Biochemical Engineering, Bioengineering, Biochemistry, Biology, or related scientific field
Thorough knowledge of biotechnology process development methodologies such as cell culture, aseptic techniques, bioreactor operation and development, column chromatography, filtration, and UFDF
Knowledge of GMP biopharmaceutical manufacturing, including process validation and commercial manufacturing support
Excellent verbal and written communication skills
Good documentation and presentation skills
Proven skills building and maintaining productive relationships with organizational partners such as Manufacturing and Quality
Ability to troubleshoot and challenge status quo processes and influence in a team environment
Ability to communicate complex results (e.g. hybrid models) to both internal and external stakeholders
Must be legally authorized to work in the United States without restriction
Must be willing to take a drug test and post-offer physical (if required)
Must be 18 years of age or older
Preferred
Four-plus (4+) years' experience in late-stage process development preferred
Two-plus (2+) years' experience leading in a matrixed environment preferred
Two-plus (2+) years' experience in data science, Machine learning, and statistical analysis skills
Benefits
Opportunity to consider higher compensation above this range based on business need, candidate experience and or skills.
Role specific variable or performance based bonus
Other compensation elements
Company
Boehringer Ingelheim
Boehringer Ingelheim is a group of pharmaceutical companies that focuses on prescription medicines and animal health. It is a sub-organization of Boehringer Ingelheim.
Funding
Current Stage
Late StageLeadership Team
Recent News
2026-01-19
Company data provided by crunchbase